NO934381L - Terapeutiske sammensetninger for osteoinduksjon - Google Patents

Terapeutiske sammensetninger for osteoinduksjon

Info

Publication number
NO934381L
NO934381L NO934381A NO934381A NO934381L NO 934381 L NO934381 L NO 934381L NO 934381 A NO934381 A NO 934381A NO 934381 A NO934381 A NO 934381A NO 934381 L NO934381 L NO 934381L
Authority
NO
Norway
Prior art keywords
osteoinduction
therapeutic compositions
mammal
safe
effective amount
Prior art date
Application number
NO934381A
Other languages
English (en)
Other versions
NO934381D0 (no
Inventor
Roger Lee Stone
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO934381D0 publication Critical patent/NO934381D0/no
Publication of NO934381L publication Critical patent/NO934381L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

En fremgangsmåte for å generere ny benvekst i et pattedyr omfattende å administrere til pattedyret en sikker og effektiv mengde av en vitamin D-for-bindelse i kombinasjon med en sikker og effektiv mengde av et osteoinduktivt ekstrakt eller minst ett benmorfogent protein.
NO934381A 1991-06-05 1993-12-02 Terapeutiske sammensetninger for osteoinduksjon NO934381L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70962191A 1991-06-05 1991-06-05
US85611092A 1992-03-27 1992-03-27
PCT/US1992/004356 WO1992021365A1 (en) 1991-06-05 1992-05-26 Therapeutic compositions for osteoinduction

Publications (2)

Publication Number Publication Date
NO934381D0 NO934381D0 (no) 1993-12-02
NO934381L true NO934381L (no) 1994-01-31

Family

ID=27108286

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934381A NO934381L (no) 1991-06-05 1993-12-02 Terapeutiske sammensetninger for osteoinduksjon

Country Status (13)

Country Link
EP (1) EP0587751A1 (no)
JP (1) JPH06508140A (no)
AU (1) AU667815B2 (no)
BR (1) BR9206110A (no)
CA (1) CA2110410C (no)
CZ (1) CZ282231B6 (no)
IE (1) IE921812A1 (no)
NO (1) NO934381L (no)
NZ (1) NZ243018A (no)
PT (1) PT100567A (no)
RU (1) RU2107512C1 (no)
SK (1) SK136693A3 (no)
WO (1) WO1992021365A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674844A (en) * 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US7056882B2 (en) 1991-03-11 2006-06-06 Curis, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
DE69233559T2 (de) * 1991-08-30 2006-08-31 Curis, Inc., Cambridge Osteogenische proteine in der behandlung von metabolischen knochenkrankheiten
US6071695A (en) * 1992-02-21 2000-06-06 Creative Biomolecules, Inc. Methods and products for identification of modulators of osteogenic protein-1 gene expression
ATE180674T1 (de) * 1993-03-29 1999-06-15 Zymogenetics Inc Osteoblastswachstumfordernde zusammensetzungen die pdgf und vitamin-d enthalten
AU703445B2 (en) * 1994-06-07 1999-03-25 Stryker Corporation Methods and compositions for modulating morphogenic protein expression
US7026292B1 (en) 1995-12-12 2006-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US6048964A (en) * 1995-12-12 2000-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US6492508B1 (en) 1996-06-03 2002-12-10 United States Surgical Corp. A Division Of Tyco Healthcare Group Nucleic acids encoding extracellular matrix proteins
CA2280931C (en) * 1997-02-07 2009-05-05 Stryker Corporation Matrix-free osteogenic devices, implants and methods of use thereof
KR20100013352A (ko) * 2001-10-31 2010-02-09 알콘, 인코퍼레이티드 뼈 형태발생 단백질(ｂｍｐ), ｂｍｐ 수용체 및 ｂｍｐ 결합 단백질 및 녹내장 진단 및 치료에서 그의 용도
KR101495578B1 (ko) * 2007-04-25 2015-02-25 사이토크로마 인코포레이티드 비타민 ｄ 부족 및 결핍의 치료 방법
JP5819734B2 (ja) * 2009-02-12 2015-11-24 ストライカー コーポレイションＳｔｒｙｋｅｒ Ｃｏｒｐｏｒａｔｉｏｎ ＴＧＦ−βスーパーファミリーメンバー含有タンパク質の最小に侵襲性の全身送達のための組成物および方法
CA2752157A1 (en) * 2009-02-12 2010-08-19 Stryker Corporation Peripheral administration of proteins including tgf-.beta. superfamily members for systemic treatment of disorders and disease
RU2595804C1 (ru) * 2015-04-23 2016-08-27 Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.) Состав для получения стоматологической лечебно-профилактической пленки

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4833125A (en) * 1986-12-05 1989-05-23 The General Hospital Corporation Method of increasing bone mass

Also Published As

Publication number Publication date
CA2110410A1 (en) 1992-12-10
CZ282231B6 (cs) 1997-06-11
WO1992021365A1 (en) 1992-12-10
JPH06508140A (ja) 1994-09-14
CA2110410C (en) 1997-04-15
BR9206110A (pt) 1995-07-11
NO934381D0 (no) 1993-12-02
RU2107512C1 (ru) 1998-03-27
PT100567A (pt) 1994-01-31
AU2145492A (en) 1993-01-08
CZ262493A3 (en) 1994-07-13
EP0587751A1 (en) 1994-03-23
NZ243018A (en) 1995-12-21
SK136693A3 (en) 1994-10-05
AU667815B2 (en) 1996-04-18
IE921812A1 (en) 1992-12-16

Similar Documents

Publication Publication Date Title
NO934381L (no) Terapeutiske sammensetninger for osteoinduksjon
ES2033434T3 (es) Composicion cosmetica.
DK337888D0 (da) Desodoriserende og antimikrobiel sammensaetning til anvendelse i kosmetiske eller topiske praeparater
IT8819961A0 (it) Dispositivo protesico composito modulare di gamba e piede.
SE8504967D0 (sv) A pharmaceutical composition and a method of treating the body
DK0920309T3 (da) Konjugeret linolensyre til bevaring eller forøgelse af mineralindhold i knogler
ES2149776T3 (es) Modulacion, inducida por un morfogeno, de la respuesta inflamatoria.
RU93058532A (ru) Фармацевтическая композиция для остеоиндукции, способ генерации новой кости
GR1002802B (el) Καλλυντικες συνθεσεις και συνθεσεις περιποιησεως του δερματος
NL193399B (nl) Injecteerbare implantsamenstelling voor gebruik bij reconstructieve chirurgische behandelingen.
DE69316013T2 (de) Verwendung von phosphinate zur behandlung der osteoporose
MX9301387A (es) Metodo y composicion para el tratamiento de osteoporosis.
FI961336A0 (fi) Menetelmä silmänesteiden säilömiseksi ja koostumuksia tätä varten
SE8802869D0 (sv) Combination of pyramidine derivatives and retonoids, as separate components, for inducing and stimulating hair growth and reducing its loss
JPS5533497A (en) Silaasubstituted 1*44dihydropyridine derivative
ATE183385T1 (de) Lyopilisierte, wirkstoffhaltige emulsion
ATE250860T1 (de) Erhöhte stabilität von azadirachtin enthaltenden festen zubereitungen
DK601888D0 (da) Anvendelse af 2-pyrimidinyl-1-piperazinderivater
SE8403659D0 (sv) Synergistic pharmaceutical composition
SG49770A1 (en) Pharmaceutical preparation
ES2089387T3 (es) Tratamiento de la hipertension ocular con la ayuda de una combinacion sinergica.
DK242889A (da) Laegemiddel i form af en ud fra de peyerske plaques fremstillet organekstrakt og dets anvendelse
MX9206135A (es) Metodos
AU562828B2 (en) Morphine-vitamin b12 analgesic treatment
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin